BioCentury
ARTICLE | Company News

Avanir, Drug Royalty deal

May 5, 2003 7:00 AM UTC

AVN received a $3.6 million payment from DRI under a 2002 deal in which AVN sold DRI a portion of its North American royalty stream on cold sore drug Abreva docosanol 10% cream. AVN said the payment ...